Podcasts about life sciences

After years of carrying the weight of lead, Shannon and Cooper find a path out from under the darkness and into the sunlight.LEAD: how this story ends is up to us is an audio docudrama series that tells the true story of one child, his mysterious lead poisoning, and his mother's unwavering fight to keep him safe. A true story written by Shannon Burkett. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.Lead was produced by Shannon Burkett. Co-produced by Jenny Maguire. Featuring Amy Acker, Tom Butler, Dennis T. Carnegie, James Carpinello, Geneva Carr, Dann Fink, Alice Kris, Adriane Lenox, Katie O'Sullivan, Greg Pirenti, Armando Riesco, Shirley Rumierk, Thom Sesma, and Lana Young. Music by Peter Salett. “Joy In Resistance” written by Abena Koomson-Davis and performed by Resistance Revival Chorus. Casting by Alaine Alldaffer and Lisa Donadio. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Life Sciences in BC Guest: Wendy Hurlburt, President & CEO at Life Sciences BC Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, we went to the doctor. Oz speaks with Dr. Matthew Lungren, the Chief Scientific Officer for Microsoft Health & Life Sciences, who co-authored a study showing that AI diagnosed complex medical cases four times faster than human doctors. Dr. Lungren walked us through how multiple AI agents worked together to generate their diagnoses, what that means for the future of medicine—and how human doctors and AI could collaborate to build a more democratized healthcare system.See omnystudio.com/listener for privacy information.

In this episode of Tiny Show and Tell Us, we talk about a new and exciting biodegradable polymer that seems to outperform commercial super glues. Then we discuss a compound called sulfur hexafluoride (SF6) that is used in high voltage equipment. Not only is SF6 a potent greenhouse gas, if you breathe it in it has the opposite effect of helium — it makes your voice deep. But it can also lead to asphyxiation so you should not breathe it in. We repeat: do not breathe this gas in. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The new season of Business Class News's Race to the Start Line podcast launched with a conversation that was both deeply personal and profoundly forward-looking. Host Karl Woolfenden sat down with two leaders from Caris Life Sciences—Dr. David Spetzler, President and Chief Scientific Officer, and Dr. James Hamrick, Chairman of the Caris Precision Oncology Alliance —for a discussion on how Caris is transforming the future of cancer care. Woolfenden framed the conversation with personal reflections, sharing how recent losses in his own circle to cancer heightened his awareness of the need for innovation in oncology. “It tightened my awareness,” he said, “of how important it is to spotlight the companies and individuals driving meaningful progress.” Tackling the Complexity of Cancer Caris Life Sciences is a leader in molecular profiling and precision medicine, advancing how oncologists understand and treat cancer. Dr. Spetzler emphasized just how complicated this mission is: “Yeah, so I think what the patents demonstrate is that we're really on the cutting edge of trying to understand cancer. And the complexity of cancer is really quite staggering, because there are no two diseases that are the same.” He explained that Caris has built one of the world's largest datasets in cancer biology. “One of the things that we've been able to do is amass an enormous data set. We're approaching having profiled a million patients, and one of the great advantages that gives us is we can start to understand—from previous patients—new patients' status, and direct them towards the better drugs that are going to help them live longer.” From Science to the Patient Bedside Where Spetzler focused on the science, Dr. James Hamrick provided a clinical lens on the company's work. He reflected on his journey as both a practicing oncologist and now a leader at Caris. “The founder of Caris, and Dr. Spetzler who has been there since 2009, was always that connection point between the science and the patient. And that's where I focus—making sure what we're doing actually makes a difference in the clinic.” Hamrick highlighted the importance of ensuring that breakthroughs aren't confined to research institutions but are accessible to patients everywhere: “Too often, patients in community hospitals don't benefit from the latest advancements available at large academic medical centers. At Caris, we're working to close that gap.” Humanizing the Science The conversation underscored the human stakes of the work. Both leaders emphasized that the mission isn't just about data or discovery—it's about outcomes. Dr. Spetzler summed it up: “Science is only as valuable as the difference it makes in the real world. That's what drives us every day.” Scaling Innovation for the Future For Caris, growth means more than company expansion—it means scaling the reach of its technology so that physicians everywhere have the tools to personalize cancer care. This, Woolfenden pointed out, is a different kind of “race to the start line”: one where the finish line is measured in lives saved and futures extended. As the first episode in the series, the dialogue with Caris Life Sciences set a high standard for Race to the Start Line. It showcased how innovation, when combined with purpose, can shape industries—and in this case, save lives. 

Karolinska Institutet och University of Tokyo samarbetar inom området Life Sciences och det handlar i korthet om att identifiera skador på cellernas kromosomer - forskningen tyder på att kromosomskador ofta uppträder i samband med nya cancertumörer. Japanpodden besökte nyligen Karolinska Institutet och fick en rundvandring i lokalerna och en chans att sitta ned med projektets två eldsjälar - Katsuhiko Shirahige från University of Tokyo och Camilla Björkegren på KI. NYHETERTokyo upplever rekordlång värmeböljaTokyo upplever just nu den längsta värmeböljan i stadens historia. I tio dagar i rad har temperaturen legat över 35 grader. Sjukvården rapporterar kraftigt ökade fall av värmeslag och uttorkning. Myndigheterna uppmanar invånarna att undvika att vistas utomhus mitt på dagen. Forskare varnar för att extremvärmen är ett direkt resultat av klimatförändringar. Samtidigt pressas elnätet hårt av en rekordhög efterfrågan på luftkonditionering. Frågan väcker oro för hur Tokyo ska hantera framtida värmeböljor och hur elnätet ska stå emot trycket.Klartecken för återstartad kärnkraft i FukuokaFukuokas rätt har gett klartecken för fortsatt drift av reaktor 1 och 2 vid Sendai kärnkraftverk, som återfinns i Kagoshima län. Motståndare hänvisar till riskerna med kärnkraft och har pekat på effekterna av katastrofen i Fukushima 2011. Domstolen menar dock att säkerhetsåtgärderna nu uppfyller kraven. Beslutet är en viktig framgång för regeringen, som vill öka kärnkraftens andel i energimixen, från nuvarande ungefär en tiondel till en tredjedel. Mitsubishi skrotar planer på havsbaserade vindkraftsparkerMitsubishi Corporation meddelar att man skrinlägger tre planerade havsbaserade vindkraftsparker. Projekten, belägna i Akita och Chiba, skulle stå klara mellan 2028 och 2030. Men de skenande kostnaderna för utrustning, bränsle och transporter gör dem olönsamma, enligt Mitsubishis egna beräkningar. Höga räntor och den globala energikrisen har förvärrat situationen ytterligare. Japan riskerar därmed att missa målet om 10 gigawatt vindkraft till 2030. Mitsubishi har redan redovisat miljardförluster kopplade till satsningarna. Beslutet betraktas som ett bakslag för Japans gröna omställning.Åklagare gör husrannsakan mot oppositionspolitikerI Tokyo har åklagare genomfört en omfattande husrannsakan mot oppositionspolitikern Akira Ishii som tillhör Nippon Ishin no Kai–partiet (Japan Innovation Party)Ishii misstänks för ha tagit ut statliga medel för en sekreterare som aldrig arbetat för honom.Razzian genomfördes både i partiets huvudkontor och Ishiis egna arbetsrum Ishii själv förnekar brott och beskriver anklagelserna som politiskt motiverade. Fallet väcker frågor om korruption och ansvar i den japanska oppositionen och bedömare räknar med att ett åtal kan komma att komma under hösten, ett åtal som isåfall riskerar att skada förtroendet för hela oppositionsblocket.Kritik mot afrikanska vänortssatsningarEn satsning på vänortssamarbeten mellan japanska städer och afrikanska länder möts av motstånd. Rykten på sociala medier har felaktigt påstått att projekten innebär massinvandring. Det har lett till stadshus runt om i landet blivit nedringda. Bakom initiativet står biståndsmyndigheten JICA Japan International Cooperation Agency, som vill stärka handel och kulturutbyte. Myndigheten betonar att programmet inte har någon koppling till migration. Trots det har främlingsfientliga uttalanden fått stort genomslag. Kommuner efterlyser nu tydligare information för att bemöta desinformationen.Tokyos stad släpper AI-genererad film som visar hur huvudstaden kan drabbas vid ett utbrott från vulkanen Fuji.Askan väntas nå Tokyo inom en till två timmar och kan bli upp till tio centimeter tjock. Transporter på mark och i luften riskerar att stoppas helt, medan el- och telenäten hotas av blöt aska. Invånare uppmanas att lagra mat för tre dagar samt använda masker och skyddsglasögon. Syftet är att öka beredskapen inför ett utbrott som kan inträffa när som helst. Filmen som är tre minuter lång kan ses på Youtube . This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit japanpodden.substack.com

The deficits from the lead poisoning continue to intensify, Shannon channels her anger and grief into holding the people who hurt her son responsible.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.EP4 features Eboni Booth, Sasha Eden, Kevin Kane, April Matthis, Alysia Reiner, and Mandy Siegfried. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Laura welcomes Dr. Esther Sternberg, M.D., a Professor, Research Director, Speaker, and Author of the books Well at Work, Healing Spaces, and The Balance Within, to the podcast to talk about wellness at work and how workplace environments impact employees. Dr. Sternberg shares her career journey from her start in medical family practice through to becoming the Research Director at the Andrew Weil Center of Integrative Medicine. She and Dr. Laura talk about what factors impact health and overall wellness at work and how these can be improved.Dr. Sternberg delves into the insights in her book Well at Work and explains the seven domains of integrative health as defined by the Andrew Weil Center for Integrative Medicine. Sleep, resilience, environment, movement, relationships, spirituality, and nutrition are the seven domains, and they include things like how quickly we bounce back from stress, how clean our air is, and access to nature. Dr. Laura and Dr. Sternberg examine how office design, environmental location, common spaces that encourage relationships, and even temperature all play a key role in our workplace health. The conversation sheds light on how work isn't simply a place to invest time into productivity, but can positively or negatively impact our overall lives, and how redefining workplaces is a vital part of future discussions. “... if you're feeling too stressed or too activated, you want to do something that will tone down that stress response so you can perform at peak... If you're too stressed, you freeze, you're unable to focus. You're unable to do the job, the task at hand. So what helps you to move that stress response from the extreme danger zone back to performing at peak is places where you can go offline a little bit, where you can effectively meditate even though you're not sitting there with crossed legs in a lotus position in a yoga studio, although having spaces where some people can do that is is also beneficial. But a space, for example, [like] the gardens. To just walk in the gardens, to just take your brain off the computer for a while and focus on the green, on the plants.” - Dr. Esther SternbergAbout Dr. Esther Sternberg, M.D.:Dr. Esther Sternberg is internationally recognized for her discoveries in the science of the mind-body interaction in illness and healing, and the role of place in wellbeing. She is a pioneer and major force in collaborative initiatives on mind-body-stress-wellness and environment interrelationships. A dynamic speaker, she engages her audience with passion for her subject and compassion as a physician. Through stories, she provides listeners with many take-home tips to help them cope with stress and thrive, and to create wellbeing spaces wherever they work or live. Dr. Sternberg's three popular, highly readable, informative, and scientifically based books are inspirations for lay persons and professionals alike, seeking answers to the complexities and 21st-century frontiers of stress, place, healing, and wellness. Her award-winning book, WELL at WORK: Creating Wellbeing in Any Workspace (Little, Brown Spark, 2023) was named a Top Ten Lifestyle Book for Fall 2023 by Publishers Weekly and received the OWL (Outstanding Works of Literature) Longlist Award. Her two previous science-for-the-lay public books, Healing Spaces: The Science of Place and Well-Being and The Balance Within: The Science Connecting Health and Emotions, are landmark in its field. Healing Spaces was recognized by the President of the American Institute of Architects as an inspiration for launching the AIA's Design and Health Initiative and has inspired the implementation of healing spaces in hospitals across the country and around the world. Currently, Research Director, Andrew Weil Center for Integrative Medicine and Founding Director of the University of Arizona Institute on Place, Wellbeing & Performance, she holds the Inaugural Andrew Weil Chair for Research in Integrative Medicine and is a Research Professor of Medicine with joint appointments as Professor in Psychology, Architecture, and Planning & Landscape Architecture, and in the College of Agriculture and Life Sciences, School of Nutritional Sciences and Wellness. As Senior Scientist and Section Chief, National Institutes of Health (1986-2012), she directed the NIH Integrative Neural Immune Program, Co-Chaired the NIH Intramural Program on Research on Women's Health, and chaired a subcommittee of the NIH Central Tenure Committee. Dr. Sternberg has advised the World Health Organization; the U.S. National Academies of Sciences, Engineering and Medicine; the International WELL Building Institute; the Royal Society, London; the Vatican, where she was presented to Pope Benedict XVI; and has briefed high-level U.S. Federal Government officials, including the Surgeon General, National Institutes of Health leadership, and the Department of Defence. Her two decades-long research with the U.S. General Services Administration, using wearable devices to track health and wellbeing in the built office environment, is informing healthy design standards and COVID re-entry across the federal government and the private sector.Among other honors, she moderated a panel with the Dalai Lama, was recognized by the National Library of Medicine as one of the women who “Changed the Face of Medicine,” served as a member and Chair of NLM's Board of Regents, and received an Honorary Doctorate in Medicine from Trinity College, Dublin, on its 300th Anniversary. She has authored over 240 scholarly articles, edited 10 technical books on the topic of brain-immune connections and design and health, and writes a monthly blog for Psychology Today, it has garnered tens of thousands of readers on subjects including stress and illness, gratitude and wellness, and place and wellbeing. She co-created and hosted the PBS Television Special, The Science of Healing with Dr. Esther Sternberg, and is frequently interviewed in the lay press and media, including NPR, BBC, CBC radio; PBS, ABC, CBS 60 Minutes, Overtime television, the Washington Post, LA Times, U.S. News and World Report, Reader's Digest, Prevention Magazine, The Oprah Magazine, and numerous podcasts, among others. She received her M.D. from McGill University, and trained in rheumatology at the Royal Victoria Hospital, Montreal, Canada.Resources:Website: EstherSternberg.comBook: “Well at Work: Creating Wellbeing in any Workspace” by Esther M. Sternberg, MDInstagram: @dresternbergLinkedInLearn more about Dr. Laura on her website: https://drlaura.liveFor more resources, look into Dr. Laura's organizations: Canada Career CounsellingSynthesis Psychology

In today's Cloud Wars Minute, I explain how Oracle is transforming healthcare with its AI-driven, cloud-native EHR, setting a bold path toward intelligent care.Highlights00:02 — Oracle has introduced an updated version of Oracle Health EHR, or Electronic Health Record, for ambulatory providers in the U.S., built on Oracle Cloud Infrastructure. The new system features native AI agents that operate together as an orchestrated system for maximum process efficiency.00:29 — The new Oracle Health EHR, was designed in collaboration with frontline providers and delivers the services that they require in a manner that's most useful to them. For example, it features personalized, streamlined workflows. In 2026, Oracle plans to enhance the system to include acute care, further expanding the reach of this groundbreaking technology.00:50 — Now, this represents a major leap forward for healthcare providers, and Oracle is right to focus significant efforts in this direction, enabling clinicians to cut through the administrative burdens of the healthcare industry. Identified as one of the first major use cases for generative AI, it remains a priority, and Oracle is certainly thinking big in this area.01:13 — In fact, Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, said the following: "When Oracle committed to transforming the healthcare industry, we knew we had to start with the EHR." Note the commitment to not just supporting, but "transforming" the healthcare industry. Visit Cloud Wars for more.

Matters Microbial #104: Antibiotic “Tolerance” and Biofilms August 21, 2025 Today, Dr. Boo Shan Tseng, Associate Professor at the University of Nevada Las Vegas School of Life Sciences, joins the #QualityQuorum to discuss bacterial biofilms and antibiotic tolerance.  Host: Mark O. Martin Guest: Boo Shan Tseng Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A video overview of biofilms. A comprehensive review article on biofilms. An article describing the impact biofilms have on disease. An article describing the impact of biofilms on implanted medical devices. A link to the Center for Biofilm Engineering at Montana State University that has MANY links of interest. An overview of biofilm development. An overview of confocal laser microscopy. Studying biofilms in flow cells. An article about the role proteins play in biofilm formation, which intersects with the Tseng group's research. The technique of single cell RNA seq. The technique of mRNA-FISH. An article about porins in bacteria, and how that can relate to antibiotic resistance. An article by Dr. Tseng and coworkers on the eDNA and biofilms discussed today. A lovely video of Dr. Tseng talking about the research she and her colleagues carry out in the laboratory. Dr. Tseng's biography from the American Society for Microbiology. Dr. Tseng's laboratory group website with wonderful links and images. Dr. Tseng's faculty website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Jim talks with Lawrence Cahoone about the ideas in his book The Orders of Nature: An Introduction to the Philosophy of Complex Systems for the Life Sciences. They discuss how Cahoone's naturalist philosophy bridges multiple philosophical domains, his distinctive use of emergence theory borrowed from William Wimsatt, the concept of "no simples" in objective relativism, the role of Prigogine in emergence theory, Cahoone's self-taught approach to understanding physics and science, fallibilist and local metaphysics, Columbian naturalism and its rejection of the supernatural, the relationship between objects and their contexts, scientific explanations of relativity and quantum mechanics, and much more. Episode Transcript The Orders of Nature: An Introduction to the Philosophy of Complex Systems for the Life Sciences, by Lawrence Cahoone The Emergence of Value: Human Norms in a Natural World, by Lawrence Cahoone The Feynman Lectures on Physics, by Richard Feynman Lawrence Cahoone graduated with a Ph.D. in Philosophy at Stony Brook University in 1985. Cahoone's areas of specialization are American Philosophy, Continental Philosophy, Social and Political Philosophy, Philosophy of Culture, Metaphysics and Natural Science and Modernism and Postmodernism. Since 2000, Cahoone has taught at Holy Cross and is now currently an Emeritus Professor of Philosophy at Holy Cross. He has also written and published seven books in his career, including The Emergence of Value, The Orders of Nature, and Cultural Revolutions.

After some years developing websites and interactive and digital marketing projects, Guillem joined Merck in 2009, and he has been always related to digital marketing projects on the business side. Since 2020 Guillem has been driving the Social Selling initiative for Merck Life Science, focusing on Social Scouting with LinkedIn Sales Navigator, Social Listening and Employee Advocacy, to help Sales teams be more effective by using social channels to uncover new business opportunities. His work with using Chat CPT to support employee content has been truly inspiring with some great results. Folllow him on Linkedin for more https://www.linkedin.com/in/guillemcardenal/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Hamid Ghanadan, CEO at LINUS, reports on their recent State of Science research that tracks scientists' sentiment, funding expectations, and barriers to their work. Key findings reveal that the politicization of science and erosion of public trust in science threaten to slow innovation rates and negatively impact public access to accurate information. The survey also shows a direct negative impact on scientists' morale, job satisfaction, and creativity. We talk about: The growing perception of the public that science is not real Sources of public distrust of scientific information When scientists become politically active  Need for more direct communication from the scientists and life science leaders to make complex topics more understandable and relevant Opportunity for researchers, institutions, vendors, and advocacy groups to recognize these issues and take responsibility to improve the communication of accurate health and medical information to a broader audience #TheLINUSGroup #Scientists #MedicalResearchers #PublicTrust #PoliticizationofScience #HealthcareInformation #MedicalInformation  TheLINUSGroup.com

An estimated 132 million babies were born across the globe last year — really just a drop in the bucket when you think about the over 100 billion babies born since modern humans first lived on Earth 200,000 years ago. And until very recently we had few tools to understand how they were doing in the womb, how they would fare in the days after birth, and how a pregnant person would change physically and mentally not just during pregnancy but in the months and years that followed. Things have changed dramatically, particularly over the last decade, in terms of the care and technology that's available preconception, during pregnancy, and post-birth. But there is still so much we don't know about these time periods, both for baby and mom, and many a black box remains. Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode of Digital Squared: From the Archives, we're revisiting a conversation with Ed Marx, Chief Digital Officer for Tech Mahindra Health and Life Sciences and formerly the CIO at Cleveland Clinic and NYC Health & Hospitals. Ed is full of enthusiasm, curiosity and drive, and he has used those tools to expand his own horizons and to act as catalyst to define the role of the post-modern CIO for the healthcare industry.

The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“More technology, more life science and healthcare:” Scott Sperling believes these are what will fuel the future. He also sees opportunities in logistics and thinks more businesses will “fundamentally tweak” their models with technology to become more efficient and prosperous. On the Fed, he says the best option is a 25 basis point rate cut in September. He also brings the case that the Fed is losing control over the 10-year.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

  The Garden State, called the “medicine chest” to the world, continues to show robust activity with life sciences firms accounting for nearly 30% of all Q2 leasing activity. Greg Slabodkin   Read by Brittany Duncan    https://www.pharmamanufacturing.com/all-articles/article/55308250/new-jersey-remains-hot-life-sciences-hub-despite-macroeconomic-funding-headwinds 

Welcome to Automating Quality, the life sciences–focused show that bridges the gap between automation and quality management. In today's episode, our host Philippe welcomes Jim Ferguson, President and Owner of NuQual Consulting. With over 25 years of experience in the life sciences industry, Jim brings deep expertise in supplier quality and compliance. Together, they dive into the world of internal audits — how they can be used not only to maintain compliance but also to proactively identify and resolve potential observations before a regulatory inspection takes place.   Key Takeaways 01:22 Introducing today's guest, Jim Ferguson from NuQual Consulting 02:18 What quality-focused events has Jim been attending lately? 04:30 How can internal audits help organizations prepare for regulatory inspections or other types of audits? 07:25 What is the value of outsourcing internal audits? 08:35 How can companies ensure that audit findings actually lead to meaningful changes? 12:57 What does a strong response to internal audit findings look like? 17:30 What are some common pitfalls organizations tend to overlook during internal audits?   Contact Jim at https://nuqualconsulting.ca/ Contact us at solabs-podcast@solabs.com

McAndrew Rudisill, Board Chair for ETHZilla, joined me to discuss ETHZilla's Ethereum corporate treasury.Topics:- 180 Life Sciences Corp rebrand to ETHZilla - Choosing Ethereum as a treasury asset - Ethereum staking and DeFi - Crypto Treasury strategy risks - Crypto Legislation & Market Outlook 

Jack Moody is back hosting this week and we catch up on the racing from the weekend. We revisit our interview with Dr. Philip Hurst, former middle-distance runner and current academic from the School of Psychology and Life Sciences at Canterbury University. We discuss the intriguing world of the 'placebo effect', its negative counterpart - the 'nocebo effect' and their impact on sports performance. Drawing from his research and experience, Dr. Hurst shares the significance of these effects in the medical world and how they have the potential to shape athlete performance. (0:00:00) – Calling in from Prague (0:04:20) – Prague – a wetsuit race (0:06:41) – Charlotte McLauchlan study  (0:09:08) – IM703 Melbourne competition                        (0:11:12) – Racing from the weekend (0:24:22) – IM703 Hradec-Kralove (Prague) (0:43:04) – Dr Philip Hurst LINKS: Follow Jack Moody on Instagram at https://www.instagram.com/jacktmoody/ Dr Philip Hurst's review “The Placebo and Nocebo effect on sports performance: A systematic review” at https://pubmed.ncbi.nlm.nih.gov/31414966/ Follow Dr Philip Hurst on Twitter at https://twitter.com/Phil_Hurst1 IRONMAN 70.3 Hradec-Kralove (Prague) at https://www.ironman.com/races/im703-hradec-kralove Charlotte McLauchlan can be contacted by email at cmcl126@aucklanduni.ac.nz Fitter Radio Episode 613 – Interview with Charlotte McLauchlan at https://www.fitter.co.nz/fitter-radio/2025/4/12/episode-613-confidence-nutrition-and-the-mind Plasmaide at https://plasmaide.com/

Melissa Sleeper is a National Board Certified Teacher currently teaching Life Science and Space Science at Holy Trinity Episcopal Academy in Melbourne, Florida. A career changer, Melissa worked as an Agriculture Economist/Statistician setting up crop reporting services and running rural household surveys. She lived and taught in both public and private schools in Morocco, Egypt, Grenada, Barbados, Bolivia, and Nicaragua in addition to her extensive work here in the States. Melissa has the unique experience of being able to say she has taught at every grade level from pre-K to adult.. Melissa an active member of the National Science Teaching Association, The AIAA and has served on, among others, the Aerospace Advisory Board and National Middle Level Science Teachers Association. Her passion for space education was flamed when she was selected an Educator Ambassador for NASA's MAVEN Mission. We are grateful to know such a passionate STEM educator and we know you will appreciate Melissa as much as we do. SmallSat Education Conference:

AI systems can do amazing things, but they can sometimes suffer from a drawback called “catastrophic forgetting”. Researchers at Arizona State University hope to learn how to solve the problem by probing the brains of sleeping bees. The pay-off could be more reliable, more memory-efficient artificial intelligence. When AI systems learn one task — say, how to recognize dogs — and are later trained on a new task — like identifying cars — they often forget the first thing they learned. This is called ctastrophic forgetting. Ted Pavlic is an associate professor of computer science and engineering in the School of Computing and Augmented Intelligence, part of the Ira A. Fulton Schools of Engineering at ASU, with a joint appointment in the School of Life Sciences. He leads a unique interdisciplinary research project that blends biology and computer science.

Building Maryland's BioHealth Future: Maryland Commerce's Stefanie Trop on Growing the Life Sciences Sector In this episode of BioTalk with Rich Bendis, Stefanie Trop, Ph.D., Director of Life Sciences at the Maryland Department of Commerce joins the conversation to discuss Maryland's position as a leading life sciences hub. Stefanie shares how the Department of Commerce supports company attraction and growth through programs like Global Gateway, and how it's amplifying the state's recent #3 biopharma hub ranking. The discussion also explores Maryland's unique ecosystem, including the work of the Governor's Life Sciences Advisory Board, the state's leadership in computational health, and the importance of industry collaboration during BioHealth Capital Region Week. Editing and post-production work for this episode was provided by The Podcast Consultant. Dr. Stefanie Trop brings a unique blend of hands-on scientific expertise and high-level strategic insight. With a Ph.D. in Molecular Microbiology and Immunology, she has worked at the ground level in immunology, clinical trials, and vaccine development, while also driving growth through scientific partnerships and business development. Her deep understanding of the science and passion for problem solving guides her ability to build effective collaborations that advance both innovation and commercial success. At the Maryland Department of Commerce, Stefanie works to connect Maryland's life sciences companies with national and global resources, expanding the industry's impact at home and globally. In current and prior roles, she bridges communication gaps between scientific and business teams, ensuring that customer needs translate into innovative products and business wins.

As AI becomes deeply embedded in every industry, building AI systems that are secure, responsible, and privacy-centric is more crucial than ever. But where do you begin? At the strategy level? Design? Or implementation? How do organizations tackle the challenges of AI risks, data governance, and compliance while keeping pace with innovation?Join us for an insightful conversation with Punit Bhatia and Santosh Kaveti, CEO of Pro Arch, as we explore the evolving landscape of responsible AI, key foundational steps, and the practical approaches to secure AI deployment.If you're looking to understand how to build AI systems that are not only innovative but also secure and trustworthy, this episode is for you!KEY CONVERSION 00:01:58 Responsible AI 00:04:30 AI Strategy 00:11:43 Role of standards and Approach 00:15:35 Good practices of Data Governance 00:19:55 AI Talent 00:23:10 Pro Arch Role in costumers 00:25:00 Contact Information of Santosh  ABOUT GUEST Santosh Kaveti is CEO & Founder at Proarch. With over 18 years of experience as a technologist, entrepreneur, investor, and advisor, Santosh Kaveti is the CEO and Founder of ProArch, a purpose-driven enterprise that accelerates value and increases resilience for its clients with consulting and technology services, enabled by cloud, guided by data, fueled by apps, and secured by design. Santosh's vision and leadership have propelled ProArch to become a dominant force in key industry verticals, such as Energy, Healthcare & Lifesciences, and Manufacturing, where he leverages his expertise in manufacturing process improvement, mentoring, and consulting. Operationalizing AI: From Strategy to Execution Navigating AI Risks: Ensuring Security and Compliance Prioritizing AI Initiatives: Aligning with Business Goals Attracting and Retaining Top AI Talent Integrating AI into Core Business Functions The Data Foundation: Governance, Quality, and Culture in AI  Santosh's journey is marked by resilience, ambition, and self-awareness, as he has learned from his successes and failures, and continuously evolved his skills and perspective. He has traveled across 23 countries, gaining insights into the global diversity and interconnectedness of human experiences. He is passionate about blending technology with a human-centric approach and making a meaningful societal impact through his support for initiatives that uplift underprivileged children, assist disadvantaged families, and promote social awareness.Santosh's ethos extends to his investments in and mentorship of promising startups, as well as his role as the Chairman of the Board at Enhops and iV4, two ProArch companies.  ABOUT HOST Punit Bhatia is one of the leading privacy experts who works independently and has worked with professionals in over 30 countries. Punit works with business and privacy leaders to create an organization culture with high privacy awareness and compliance as a business priority. Selectively, Punit is open to mentor and coach professionals.  Punit is the author of books “Be Ready for GDPR' which was rated as the best GDPR Book, “AI & Privacy – How to Find Balance”, “Intro To GDPR”, and “Be an Effective DPO”. Punit is a global speaker who has spoken at over 30 global events. Punit is the creator and host of the FIT4PRIVACY Podcast. This podcast has been featured amongst top GDPR and privacy podcasts.  As a person, Punit is an avid thinker and believes in thinking, believing, and acting in line with one's value to have joy in life. He has developed the philosophy named ‘ABC for joy of life' which passionately shares. Punit is based out of Belgium, the heart of Europe.  RESOURCES Websites www.fit4privacy.com,www.punitbhatia.com, https://www.linkedin.com/in/santoshkaveti/ , https://www.proarch.com/  Podcast https://www.fit4privacy.com/podcast Blog https://www.fit4privacy.com/blog YouTube http://youtube.com/fit4privacy   

ETHZilla is one of the latest companies to take a page from the MicroStrategy playbook and completely transform into a crypto treasury firm. ETHZilla, currently trading under its original name 180 Life Sciences, just scored a significant investment from Peter Thiel, whose associated funds amassed a 7.5% stake. That news, paired with the announcement that ETHZilla is now holding more than 82,000 ETH, caused the stock to more than triple in a single day. Executive Chairman McAndrew Rudisill speaks with host Zaid Admani about the company's vision for ethereum and what Peter Thiel's investment signals about the future of the digital asset.The content of the video is for general and informational purposes only. All views presented in this show reflect the opinions of the guest and the host. You should not take a mention of any asset, be it cryptocurrency or a publicly traded security as a recommendation to buy, sell or hold that cryptocurrency or security. Guests and hosts are not affiliated with or endorsed by Public Holdings or its subsidiaries. You should make your own financial and investment decisions or consult respective professionals. Full disclosures are in the channel description. Learn more at Public.com/disclosures.Past performance is not a guarantee of future results. There is a possibility of loss with any investment. Historical or hypothetical performance results, if mentioned, are presented for illustrative purposes only. Do not infer or assume that any securities, sectors or markets described in the videos were or will be profitable. Any statements of future expectations and other forward-looking statements are strictly based on the current views, opinion, or assumptions of the person presenting them, and should not be taken as an indicator of performance nor should be relied upon as an investment advice.

In this episode of Tiny Show and Tell Us, we talk about breathing in birds — how it takes two breath cycles for air to leave their bodies, and while it travels within their bodies, it's stored in various sacks, some of which are in their butts. Then we discuss how food waste contributes to approximately 8% of global greenhouse gas emissions every year, and what we can do to reduce it. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The CEO of adMare BioInnovations unpacks the profits, principles, and policies shaping today's life sci industry. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today's guest is Dr. Steffen Hoffmann, Managing Director of Bosch UK. Dr. Hoffmann joins Emerj Editorial Director Matthew DeMello to explore the strategic deployment of AI across industrial sectors, from manufacturing operations to internal business systems. Dr. Hoffmann shares how AI is helping manufacturers address upstream process variables to reduce defect rates and improve efficiency. He also discusses the importance of “human in the loop” oversight in regulated environments, and how Bosch's internal deployment of generative AI — starting with an HR assistant — serves as a model for cautious, business-aligned innovation. The conversation explores industrial applications of AI governance, the role of internal use cases in de-risking new technologies, and the broader cultural conversation around balancing AI's risks and rewards. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Predictable hiring isn't just possible —it's essential. On this episode, host Ryan Dull is joined by Michael Peterson, Sr. Director of Global Talent Acquisition – Talent Sourcing, Intelligence and Innovation at Edwards Lifesciences, to explore how strategic planning, data-driven practices and a consumer-minded approach are shaping modern TA functions in highly regulated industries. Michael walks through his path from aspiring pilot to TA leadership, sharing lessons from roles across healthcare, tech and international organizations. From building teams from scratch to redefining success metrics, Michael also offers practical insights into the evolving TA landscape.Key Takeaways:(00.00) Introduction.(02:35) Michael pivoted from aviation to a career in TA leadership.(04:48) Edwards Lifesciences leads in heart valves, with 17 on Michael's TA team.(05:59) Intelligence and innovation functions are early, with one analytics role in place.(07:58) The Valencia plant proves the strategy works and uncovers key process gaps.(10:11) TA taught the business the market's tough — now it's about how to act on it.(12:52) Quality of hire is the top priority, even if measurement still needs work.(15:12) TA priorities include field roles, tech optimization and guiding AI innovation.(17:01) Focus on doing the right thing, not on being liked.Resources Mentioned:Michael Petersonhttps://www.linkedin.com/in/taleadermichaelkpeterson/Edwards Lifesciences | LinkedInhttps://www.linkedin.com/company/edwards-lifesciences/Edwards Lifesciences | Websitehttps://www.edwards.com/This episode is brought to you by Sagemark HR.Sagemark HR can help you:✔ Improve your talent practices and make better, more informed people decisions.After 20+ years of experience leading Recruiting and Talent Acquisition across a wide variety of industries, I've seen enough hires (over 100,000 to date) to know that hiring decisions truly can make or break an organization.✔ Identify opportunities to not only improve your talent practices, but also delivering tangible business results.We understand every organization is different, and there's no one-size-fits-all magic solution. So we listen first and identify the gaps and sticking points in your current process before ever recommending a solution.✔ Bridge the gap from “traditional” to modern recruiting, without the painful learning curve.We believe recruiting, talent, and HR technology is a deep well of untapped business potential, and our mission is to help you identify and implement those hiring tools in a way that works for you.If you're interested in learning more, you can reach me at:www.sagemarkhr.com✉ ryan.dull@sagemarkhr.com#Talent #Recruiters #Recruiting #HRTech

The FDA has begun urging manufacturers to treat cybersecurity risk management as a material business concern. Hal Porter, Director of Consulting Services, Clearwater, speaks with Allyson Maur, Associate, McGuireWoods, about the implications of the FDA's growing focus on cybersecurity as a core component of medical device safety and financial risk and what that shift means for legal, compliance, and risk professionals. They discuss how manufacturers and providers should navigate these expectations, how legal teams can prepare for regulatory scrutiny, and how cyber risk in the device ecosystem is quickly becoming a board-level issue. Sponsored by Clearwater.Watch this episode: https://www.youtube.com/watch?v=3Y9R5kwRqeULearn more about Clearwater: https://clearwatersecurity.com/ Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Medicine stands at the threshold of a new era, where artificial intelligence and systems biology are working hand in hand to make care more personal, predictive, and precise than ever before. AI is already improving diagnostic accuracy, automating administrative tasks, and uncovering patterns in data—like retinal scans or genomics—that humans often miss. Rather than replacing doctors, AI enhances their ability to deliver more informed, precise, and efficient care. At the same time, individuals are gaining tools—from at-home diagnostics to wearable biosensors—that empower them to track and optimize their own health. This shift marks a move from reactive, disease-centered care to a proactive, data-driven model of scientific wellness. In this episode, I talk with Dr. Eric Topol, Dr. Nathan Price, Dr. Leroy Hood, Dr. Vijay Pande, and Daisy Wolf about how artificial intelligence, personalized data, and wearable technology are converging to radically transform medicine. Dr. Eric Topol is Executive Vice President of Scripps Research and founder/director of its Translational Institute, recognized as one of the top 10 most cited researchers in medicine with over 1,300 publications. A cardiologist and author of several bestselling books on the future of medicine, he leads major NIH grants in precision medicine and shares cutting-edge biomedical insights through his Ground Truths newsletter and podcast. Dr. Nathan Price is Chief Scientific Officer at Thorne HealthTech, author of The Age of Scientific Wellness, and a National Academy of Medicine Emerging Leader. He also serves on the Board on Life Sciences for the National Academies and is Affiliate Faculty in Bioengineering and Computer Science at the University of Washington. Dr. Leroy Hood is CEO and founder of Phenome Health, leading the Human Phenome Initiative to sequence and track the health of one million people over 10 years. A pioneer in systems biology and co-founder of 17 biotech companies, he is a recipient of the Lasker Prize, Kyoto Prize, and National Medal of Science. Dr. Vijay Pande is a General Partner at Andreessen Horowitz and founder of a16z Bio + Health, managing over $3 billion in life sciences and healthcare investments at the intersection of biology and AI. An Adjunct Professor at Stanford, he is known for his work in computational science, earning honors like the DeLano Prize and a Guinness World Record for Folding@Home. Daisy Wolf is an investing partner at Andreessen Horowitz, specializing in healthcare AI, consumer health, and healthcare-fintech innovation. She previously worked at Meta and in various startups, holds a JD from Yale Law, an MBA from Stanford, and a BA from Yale, and is based in New York City. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Can AI Fix Our Health and Our Healthcare System? The Next Revolution In Medicine: Scientific Wellness, AI And Disease Reversal The Future of Healthcare: The Role of AI and Technology

Structural heart innovation is rewriting the future of cardiovascular care—delivering faster recoveries, better outcomes, and a new standard of precision through less invasive procedures. Breakthroughs in imaging, smarter device design, and real-time data are empowering doctors to tackle even the most complex heart conditions with unmatched accuracy. Leading this heart-health revolution is Edwards Lifesciences, a global pioneer changing the way the world treats cardiovascular disease. CEO Bernard Zovighian goes Inside the ICE House to discuss how, under his leadership, the company is breaking boundaries and saving lives - pne innovation at a time.

Aligning Culture, Talent & Strategy for Scalable Growth with Dr. Kallol Biswas, Ph.D. In this powerful episode of The Hurricane H Show, we sit down with Dr. Kallol Biswas, Ph.D. — a global leadership expert, Principal Consultant, and Fractional Executive with over 20 years of experience leading high-performance teams across pharma, biotech, and medical devices. Together, we explore how organizations can align culture, talent, and business strategy to unlock scalable growth — especially in today's fast-evolving, innovation-driven world. Dr. Biswas shares key insights on transforming technical leaders into strategic influencers, building trust across global teams, and the growing role of fractional leadership in regulated industries. Whether you're a CEO, team leader, HR executive, or an emerging professional in life sciences, this episode will shift how you view leadership, execution, and long-term performance. Topics Covered: Leadership transformation in pharma & biotech Aligning culture with strategy and execution Fractional executive insights Scaling high-performance teams globally The future of life sciences leadership

Aligning Culture, Talent & Strategy for Scalable Growth with Dr. Kallol Biswas, Ph.D. In this powerful episode of The Hurricane H Show, we sit down with Dr. Kallol Biswas, Ph.D. — a global leadership expert, Principal Consultant, and Fractional Executive with over 20 years of experience leading high-performance teams across pharma, biotech, and medical devices. Together, we explore how organizations can align culture, talent, and business strategy to unlock scalable growth — especially in today's fast-evolving, innovation-driven world. Dr. Biswas shares key insights on transforming technical leaders into strategic influencers, building trust across global teams, and the growing role of fractional leadership in regulated industries. Whether you're a CEO, team leader, HR executive, or an emerging professional in life sciences, this episode will shift how you view leadership, execution, and long-term performance. Topics Covered: Leadership transformation in pharma & biotech Aligning culture with strategy and execution Fractional executive insights Scaling high-performance teams globally The future of life sciences leadership

John Maytham chats to Dr Rosa Busquets from Kingston University, School of Life Sciences, Pharmacy and Chemistry, about microplastics in human blood, and procedures that claim to be able to remove them. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

When it comes to artificial intelligence, the tables are turning and there is a shift in considering it a hype to understanding that AI is a real necessity. And 2025 is becoming a turning point wherein practical, embedded AI begins to scale. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Florian Schnappauf, VP, enterprise commercial strategy Europe, at Veeva Systems. The conversation covers commercial model evolution, precision engagement, the importance of quality data in a personalisation strategy, and – of course – compliance. You can also listen to episode 197a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

3,500 years ago, cats started showing up in Egyptian paintings on tomb walls and in sculptures and carvings. Not only were they abundant in these representations, but it was very clear that they were domestic. They had collars around their necks and were eating out of food dishes underneath the dining room table. That scene is not so different from the life many cats lead today. So how did cats go from the wild to being immortalized on tomb wall paintings and lounging on living room couches? And just how domestic is a domestic cat?Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of The Dish on Health IT, Tony Schueth and Rob Dribbon are joined by Neikisha Charles Director of Quality Improvement and Risk Management of Bedford Stuyvesant Family Health Center (Bed-Stuy), a federally qualified health center (FQHC) in Brooklyn, NY. Together, they dig into common misconceptions about FQHCs and shine a spotlight on the opportunities they present for strategic engagement across the healthcare ecosystem—especially for health IT and life sciences organizations.Neikisha opens with her personal journey: starting as a data analyst at Bed-Stuy in 2021 and quickly rising into her current leadership role because of her knack for using data to drive quality improvement. Her story illustrates the increasing sophistication of FQHCs and sets the tone for a broader conversation about how these organizations are evolving.To help orient listeners who may not fully understand the role of FQHCs, Neikisha provides a clear definition: FQHCs are federally funded community-based providers mandated to offer care to all residents in underserved areas, regardless of insurance status. They are deeply attuned to social determinants of health and committed to removing access barriers for vulnerable populations.Rob adds context from his years in pharma, highlighting the unique value proposition of FQHCs—namely, their holistic and integrated approach to care. He urges listeners not to overlook these organizations simply because they've historically focused on commercial health systems.Neikisha then debunks a major myth: that FQHCs only serve uninsured or homeless patients. In fact, Bed-Stuy primarily serves Medicaid-managed populations, but also sees commercially insured and uninsured individuals, offering services on a sliding scale. Services range from primary care and mental health to dental, podiatry, and optometry, along with extensive care coordination and social support services.When asked what health IT vendors and life sciences companies may be missing, Neikisha makes it clear: FQHCs are not tech or data-poor. Bed-Stuy uses a robust EHR (eClinicalWorks), the Azara DRVS population health platform, and Artera for two-way patient communication. These tools aren't just window dressing—they are integrated into care delivery to close gaps, improve compliance, and monitor population health in real time.She offers a compelling case study: When colorectal cancer screening rates began to drop, Neikisha led a data-driven campaign using Azara to identify noncompliant patients, Artera to send targeted outreach texts, and a partnership with Exact Sciences to offer Cologuard kits to patients by mail. The result? A 12.3% increase in screening compliance over 18 months.Rob underscores the significance of this approach—not just the smart use of technology, but also the community-level relationships and the trust that make this kind of intervention effective.The discussion then shifts to interoperability. Neikisha notes the complexities of data exchange and the importance of dedicated roles like a Director of Health Integration to manage relationships and reporting. Bed-Stuy is connected to a regional health information organization (RHIO), uses platforms like Azara to track transitions of care, and maintains read-only EMR access with key partners to streamline care coordination. While true vendor-agnostic interoperability remains elusive, FQHCs are actively working with what's available.Tony brings the conversation back to the bigger picture: What gaps do vendors and life sciences partners need to close? Neikisha points to the need for better education about what FQHCs actually do and who they serve. She challenges companies to co-create solutions with FQHCs—offering tools that reflect real-world workflows and support sustainable partnerships rather than transactional engagements.The episode wraps with both Rob and Neikisha emphasizing the untapped potential of FQHCs. With over 30 million Americans relying on them for care, these organizations are not fringe players—they are essential infrastructure. And as Neikisha puts it, they're “here to stay.” To partner successfully, the first step is simple: reach out, learn what's needed, and build something meaningful together.Related ContentWhat Are FQHCs, & Should Life Sciences Manufacturers Even Care About Them?HIT Perspectives May 2025: FQHC Myth vs Fact Bedford Stuyvesant Family Health Center Brooklyn NY - Primary Care Services 

A mysterious dust fills a young family's apartment. The truth begins to unravel when the mother gets a call from the pediatrician - the monster deep within the walls has been unleashed. LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett. EP1 features Zak Orth, Jenny Maguire, Daphne Gaines, and Micheal Gaston. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“Saturday Mornings Show” host Glenn van Zutphen and co-host Neil Humphreys speak to Grant Abel, Assistant Vice-President of Life Sciences at Singapore Oceanarium at Resorts World Sentosa’s revamped and leading ocean institute, to inspire greater knowledge, love, and action for the ocean and aquatic life.See omnystudio.com/listener for privacy information.

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, sits down with Nicole Montgomery, Shannon O'Shea, and Phil Sclafani to unpack the sweeping implications of the newly signed One Big Beautiful Bill Act (OBBBA). With nearly a third of the bill dedicated to healthcare, the team explores how this landmark legislation will reshape coverage, funding, and delivery across the payer, provider, and pharma landscape.Discussion highlights:The OBBBA introduces new work requirements and eligibility rules that could lead to coverage loss for over 13 million people, placing new burdens on payers and statesProviders face increased uncompensated care, especially in rural areas, with added administrative complexity and a push toward technology and alternative care modelsPayers are bracing for membership loss, reduced Medicaid funding, and increased administrative load as new eligibility rules take effectPharma may see reduced demand from public programs but gains through an orphan drug exemption and incentives for domestic manufacturingThe bill's sweeping changes will disrupt healthcare, but with foresight, organizations can model financial impact, prepare for operational disruption, and plan strategic responsesSpeakers:Glenn Hunzinger (host), Health Industries Leader, PwCShannon O'Shea, Principal, Health Transformation, Provider Clinical Transformation, PwCPhil Scalfani, Principal, Customer Transformation, Pharmaceutical & Life Sciences, PwCNichole Montgomery, Principal, Health Transformation, Health Services, PwCLinked Materials:https://www.pwc.com/us/en/industries/health-industries/library/impact-of-obbba-on-us-health-system.html https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.htmlFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Brian Dean Abramson, Adjunct Professor of Vaccine Law, Florida International University College of Law and University of Houston Law Center, speaks with Vanessa Burrows, Partner, Simpson Thacher & Bartlett LLP, and Dr. René Najera, Director of Public Health, College of Physicians of Philadelphia, about the rapidly changing environment of vaccine law and regulation. They discuss current availability, recommendations, and funding of vaccines at the federal level; implications for companies involved in vaccine testing, development, distribution, and administration; the future of employer mandates; changes at the state level; and developments related to the National Vaccine Injury Compensation Program. Brian is the author of AHLA's Vaccine, Vaccination, and Immunization Law, Third Edition.Watch this episode: https://www.youtube.com/watch?v=PLaXvbvZ7cQLearn more about the book: https://store.lexisnexis.com/ahla/products/ahla-vaccine-vaccination-and-immunization-law-ahla-members-grpussku5628107m.htmlEssential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

The life sciences industry is projected to need thousands more workers over the next decade. Microcredentials are the newest way some educators and business leaders are looking to fill in-demand jobs that require specialized skills.

In this episode of Tiny Show and Tell Us, we tackle the debate surrounding whether or not it rains diamonds on Saturn. Then we talk about how UV degradation can break down some of the harmful residual dyes from plastic pollution, and what it means in the context of microplastics. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lexi Silver is 15 years old. She lost both of her parents before she turned 11. That should tell you enough—but it doesn't. Because Lexi isn't here for your pity. She's not a sob story. She's not a trauma statistic. She's a writer, an advocate, and one of the most emotionally intelligent people you'll ever hear speak into a microphone.In this episode, Lexi breaks down what grief actually feels like when you're a kid and the adults around you just don't get it. She talks about losing her mom on Christmas morning, her dad nine months later, how the system let her down, and how Instagram trolls tell her she's faking it for attention. She also explains why she writes, what Experience Camps gave her, how she channels anger into poems, and what to say—and not say—to someone grieving.Her life isn't a Netflix drama. But it should be.And by the way, she's not “so strong.” She's just human. You'll never forget this conversation.RELATED LINKS• Lexi on Instagram: @meet.my.grief• Buy her book: The Girl Behind Grief's Shadow• Experience CampsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Host Gil Bashe welcomes Sally Ann Frank the Microsoft for Startups Mentor of Microsoft. She is the global leader for health and life sciences at Microsoft for Startups, responsible for strategy, programs, and portfolio, accelerating the development of innovative, market-making companies. With more than 25 years of experience in high-tech business development, sales, and marketing, she is passionate about helping health and life sciences companies and startups use Microsoft technology to provide better, more-cost effective care. As the WW Lead for Health & Life Sciences at Microsoft for Startups, she work directly with founders, VCs, M12 and others in the industry to partner with Microsoft and accelerate their development and growth. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Michelle Andrews built a career inside the pharma machine long before anyone knew what “DTC” meant. She helped launch Rituxan and watched Allegra commercials teach America how to ask for pills by name. Then she landed in the cancer fun house herself, stage 4 breast cancer, and learned exactly how hollow all the “journey” slide decks feel when you're the one circling the drain.We talk about what happens when the insider becomes the customer, why pill organizers and wheat field brochures still piss her off, and how she fired doctors who couldn't handle her will to live. You'll hear about the dawn of pharma advertising, the pre-Google advocacy hustle, and what she wants every brand team to finally admit about patient experience.If you've ever wondered who decided windsurfing was the best way to sell allergy meds—or what happens when you stop caring if you make people uncomfortable—listen up.RELATED LINKSMichelle Andrews on LinkedInTrinity Life Sciences – Strategic AdvisoryJade Magazine – Ticking Time Bombs ArticleNIHCM Foundation – Breast Cancer StoryFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

From finding simple recipes to diagnosing complicated illnesses, artificial intelligence (AI) is becoming an increasingly useful part of everyday life, but the space and resources it takes to power that technology is immense and that is hitting close to home for some tribes. The Tonawanda Seneca Nation in New York just filed a lawsuit against a proposed 900,000-square-foot AI data center a mile away from their reservation. Chief Kenith Dale Jonathan says the center would harm air quality, water, and wildlife. We'll hear from the tribe and the potential for data center encroachment elsewhere. We'll also look at how the Trump administration's push to use AI in medicine would benefit or harm Native Americans. GUESTS Christine Abrams (Tonawanda Seneca), office administrator for the Tonawanda Seneca Nation Council of Chiefs Grandell “Bird” Logan (Tonawanda Seneca), media spokesperson for the Tonawanda Seneca Nation Dr. Krystal Tsosie (Diné), assistant professor in the School of Life Sciences at Arizona State University Dr. David Wilson (Diné), associate vice president for health research and professor and chair of Indigenous Health at the University of North Dakota